Stock listing

NASDAQ:EDSA Edesa Biotech, Inc. Stock

Home listing (NASDAQ) of Edesa Biotech, Inc.

Follow Edesa Biotech, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:EDSA

$2.00 USD -0.06 (-2.9%)

Close on Nov 20, 2026

Past year +15.6% · daily closes, Nov 20, 2025 – Nov 20, 2026, adjusted for splits
Day range
$1.97 – $2.18 USDNov 20, 2026
Volume
120,961 sharesNov 20, 2026
Market cap
$27.02M USDAt the close on Nov 20, 2026 · price × 13.51M shares outstanding
52-week range
$0.72 – $20.32 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
Traded on an average day
$3.57M USDMedian day 43,997 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026
Edesa Biotech, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:EDSA · Home$2.00 USD-0.06 (-2.9%)120,961$2.16$2.179$1.965$2.06Close on Nov 20, 2026

Daily closes

Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NASDAQ:EDSA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$2.00-0.06-2.9%$2.16$2.179$1.965120,961
$2.06+0.10+5.1%$2.12$2.206$1.99279,309
$1.96+0.07+3.7%$1.86$2.05$1.85324,012
$1.89-0.05-2.6%$1.94$2.00$1.735472,413
$1.94-0.14-6.7%$1.96$2.02$1.76507,554
$2.08-0.14-6.3%$2.13$2.349$1.99513,003
$2.22+0.20+9.9%$2.11$2.31$1.8511,004,859
$2.02-0.47-18.9%$2.31$2.34$1.852,111,297
$2.49+0.35+16.4%$3.47$3.93$2.3883,891,233
$2.14+0.01+0.5%$2.12$2.20$2.0137,762
$2.13-0.04-1.8%$2.14$2.179$2.1033,588
$2.17-0.11-4.8%$2.38$2.38$2.1543,997
$2.28-0.16-6.6%$2.49$2.49$2.24451,200
$2.44-0.13-5.1%$2.57$2.61$2.4044,785
$2.57-0.13-4.8%$2.86$2.86$2.55830,628
$2.70+0.14+5.5%$2.55$2.82$2.5543,636
$2.56-0.07-2.7%$2.64$2.64$2.48570,684
$2.63+0.04+1.5%$2.62$2.72$2.5725,665
$2.59-0.18-6.5%$2.71$2.74$2.54563,800
$2.77+0.01+0.4%$2.71$2.918$2.6718,142
$2.76-0.09-3.2%$2.89$2.99$2.74922,690
$2.85+0.03+1.1%$2.87$2.93$2.7039,305
$2.82+0.04+1.4%$2.81$3.025$2.8135,515
$2.78+0.21+8.2%$2.57$2.918$2.5725,039
$2.57-0.10-3.7%$2.68$2.77$2.5264,000
$2.67+0.02+0.8%$2.62$2.79$2.5475,800
$2.65-0.20-7.0%$2.84$2.84$2.6272,600
$2.85-0.09-3.1%$2.89$3.09$2.8259,700
$2.94-0.57-16.2%$3.56$3.56$2.8781,600
$3.51-0.15-4.1%$3.61$3.76$3.4936,500
$3.66-0.24-6.2%$3.96$3.96$3.6651,400
$3.90+0.18+4.8%$3.77$4.01$3.7720,100
$3.72-0.19-4.9%$3.91$4.00$3.7212,800
$3.91+0.05+1.3%$3.80$4.22$3.8069,900
$3.86-0.15-3.7%$4.01$4.01$3.8118,400
$4.01-0.20-4.8%$4.15$4.16$3.9115,500
$4.21+0.65+18.3%$3.57$4.27$3.5184,600
$3.56-0.09-2.5%$3.59$3.73$3.4741,200
$3.65-0.36-9.0%$4.04$4.04$3.6448,200
$4.01-0.02-0.5%$4.04$4.10$3.9715,500
$4.03+0.06+1.5%$3.90$4.15$3.9019,600
$3.97-0.10-2.5%$4.02$4.09$3.9725,500
$4.07-0.04-1.0%$4.02$4.20$4.0226,000
$4.11-0.03-0.7%$4.17$4.24$3.9942,000
$4.140.000.0%$4.03$4.14$4.0141,400
$4.14+0.27+7.0%$3.93$4.20$3.9124,800
$3.87-0.25-6.1%$4.08$4.12$3.8494,400
$4.12-0.02-0.5%$4.18$4.35$4.0635,000
$4.14-0.09-2.1%$4.28$4.44$4.0354,200
$4.23-0.43-9.2%$4.70$4.84$4.2326,500
$4.66-0.06-1.3%$4.80$4.90$4.6440,200
$4.72-0.01-0.2%$4.79$5.10$4.7232,000
$4.730.000.0%$4.69$4.91$4.6932,000
$4.73-0.03-0.6%$4.72$4.97$4.7236,400
$4.760.000.0%$4.74$4.87$4.6926,200
$4.76-0.02-0.4%$4.81$5.05$4.7629,800
$4.78+0.04+0.8%$4.78$5.01$4.6124,100
$4.74+0.12+2.6%$4.70$4.94$4.4591,700
$4.62+0.02+0.4%$4.65$4.93$4.5070,600
$4.60-0.34-6.9%$4.97$4.98$4.6081,200
$4.94+0.49+11.0%$4.50$5.10$4.40234,800
$4.45+0.05+1.1%$4.39$4.75$4.28112,000
$4.40-0.03-0.7%$4.45$4.60$4.12101,500
$4.43-0.33-6.9%$4.50$4.95$4.17156,200
$4.76-0.99-17.2%$5.19$6.00$4.50391,900

Splits

4 splits since 2015 · NASDAQ:EDSA · every price before a split is adjusted for it

DayRatioWhat
1-for-7Consolidation
1-for-6Consolidation
1-for-7Consolidation
1-for-10Consolidation
Ticker
NASDAQ:EDSA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Edesa Biotech, Inc. news

Edesa Biotech, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 105 in all · newest Nov 17, 2026 · oldest 2019
Decks
15 decks · latest October 2026

Where Edesa Biotech, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:EDSA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:EDSABOATSUnited StatesUSD
Tradegate:RBTTradegateGermanyEUR

Valuation

Price/book 3.1× against a median of 1.9×: 8th lowest of 11 Biotechnology companies shown. Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026

Enterprise value
$16.72M USD
P/E
Loss
EV/sales
No revenue
EV/EBITDA
No depreciation figure on 6ix yet
Price/book
3.1×
Gross margin
No revenue
Operating margin
No revenue
Net margin
No revenue
Debt to equity
0.0×
Beta vs S&P 500
0.47

Biotechnology: the 10 companies nearest in size, of 890 on 6ix with figures. Size in US dollars.

CompanyMkt capEVP/EEV/SalesEV/EBITDAP/BNet mgnDebt/EqBeta
Edesa Biotech, Inc. · NASDAQ:EDSAUS$27.02MUS$16.72Mn/an/an/a3.1×n/a0.0×0.47
Holy Stone Healthcare Co., Ltd. · TPEX:4194US$27.49MUS$25.08Mn/an/an/a7.3×n/a0.0×n/a
SoftOx Solutions AS · OSL:SOFTXUS$27.28MUS$25.25Mn/an/an/a11.6×n/a0.0×n/a
Amplia Therapeutics Ltd. · ASX:ATXUS$26.84MUS$8.63Mn/an/an/a1.0×n/a0.0×n/a
Nasus Pharma Ltd. · AMEX:NSRXUS$26.82MUS$15.11Mn/an/an/a2.4×n/a0.0×0.99
Telomir Pharmaceuticals, Inc. · NASDAQ:TELOUS$26.82MUS$22.30Mn/an/an/a6.1×n/a0.0×1.74
BriaCell Therapeutics Corp · TSX:BCTUS$26.79MUS$6.25Mn/an/an/a1.7×n/a0.0×1.07
Alterity Therapeutics Ltd. · ASX:ATHUS$26.76MUS$2.18Mn/an/an/a0.9×n/a0.0×n/a
EyePoint, Inc. · NASDAQ:EYPTUS$26.65M−US$72.44Mn/a−28.1×n/a0.3×n/a0.2×1.36
Aprogen, Inc · KRX:007460US$26.64MUS$21.31Mn/a0.2×n/a0.6×−60.1%0.6×n/a
PolTREG Spolka Akcyjna · GPW:PTGUS$26.09MUS$22.35Mn/a378×n/a2.2×n/a0.1×n/a
Median of the othersUS$26.81MUS$18.21M0.2×1.9×−60.1%0.0×1.22

Forecasts

2 strong buy · Analysts' consensus from EODHD, read Nov 16, 2026. Not 6ix's view and not investment advice.

Price target
16.33 USD · Analysts' mean
EPS, year to Sep 2026
-1.99 · 3 analysts

Team and board

OfficerRole
Par NijhawanChief Executive Officer
Peter J. WeilerChief Financial Officer
Michael BrooksPresident
Blair GordonVice President, Research and Development
Gary KoppenjanVice President, Corporate Affairs

Events

Next results
Dec 11, 2026 (expected)
QuarterResultsShare move
Q3 2026Aug 13, 2026 · After close−1.5%
Q2 2026May 14, 2026 · After close−10.7%
Q1 2026Feb 13, 2026 · After close+1.0%
Q4 2025Dec 12, 2025−17.5%
Q3 2025Aug 8, 2025 · After close−0.5%
Q2 2025May 14, 2025 · After close−1.5%
Q1 2025Feb 14, 2025 · After close−7.1%
Q4 2024Dec 13, 2024 · After close−2.1%
Q3 2024Aug 9, 2024 · After close−4.8%
Q2 2024May 10, 2024 · After close−3.9%
All 20 quarters
QuarterResultsShare move
Q1 2024Feb 9, 2024 · After close+7.9%
Q4 2023Dec 15, 2023 · After close−7.5%
Q3 2023Aug 9, 2023 · After close−3.3%
Q2 2023May 11, 2023 · After close−7.4%
Q1 2023Feb 10, 2023 · After close−2.8%
Q4 2022Dec 16, 2022 · Before open−1.0%
Q3 2022Aug 12, 2022 · After close−4.8%
Q2 2022May 13, 2022 · Before open+1.1%
Q1 2022Feb 14, 2022 · Before open−2.1%
Q4 2021Dec 28, 2021 · After close−2.7%

Open Events

Decks

DeckKindSlidesDate
Investor Presentation (October 2026)Investor deck27 slidesOctober 2026
Investor Presentation (August 2026)Investor deck27 slidesAugust 2026
ATS 2026Conference10 slidesMay 20, 2026
Investor Presentation (May 2026)Investor deck10 slidesMay 15, 2026
Investor Presentation (November 2025)Investor deck21 slidesNov 17, 2025
Investor Presentation (July 2024)Investor deck41 slidesJuly 2024
Investor Presentation (May 2024)Investor deck41 slidesMay 2024
Investor Presentation (April 2024)Investor deck39 slidesApril 2024
Investor Presentation (January 2024)Investor deck46 slidesJanuary 2024
Investor Presentation (November 2021)Investor deck36 slidesNovember 2021
All 15 decks
DeckKindSlidesDate
Investor Presentation (March 2021)Investor deck35 slidesMar 22, 2021
Investor Presentation (January 2021)Investor deck27 slidesJan 4, 2021
Investor Presentation (October 2020)Investor deck28 slidesOctober 2020
Investor Presentation (September 2020)Investor deck26 slidesSeptember 2020
Investor Presentation (September 2019)Investor deck19 slidesSeptember 2019

Open Decks

Financings

RaiseDate
Public offering of common shares (or pre-funded warrants) and accompanying common share warrants
Announced: about US$25M · US$5.5 a share · Warrants at US$7.5 · Guggenheim Securities
Dealers: Guggenheim Securities (lead)
Use of proceeds: General corporate purposes, possibly including working capital, capital expenditures, and research, development and manufacturing expenses
Aug 20, 2026
Private placement of common shares
Announced: about US$3.5M · US$4.69 a share
Buyers: Chief Executive Officer of Edesa (common shares at $5.21 per common share)
Insiders: Edesa's Chief Executive Officer is an investor in the PIPE, buying at $5.21 per common share
Use of proceeds: Advancing the vitiligo program and paridiprubart, plus working capital and general corporate purposes
Jun 11, 2026
At-the-market programme of common shares
Tranche closed: US$3.4M raised
Dec 12, 2025
Private placement of series B-1 convertible preferred shares and common shares
Closed: US$15M raised · US$1.92 a share
Buyers: Velan Capital (led the placement); Nantahala Capital; Rubric Capital Management LP; Stonepine Capital Management; Broadfin Holdings LLC
Insiders: Officers and directors purchased approximately $1.1 million of the securities sold
Use of proceeds: Advance EB06 CXCL10 antibody into a Phase 2 study in nonsegmental vitiligo, plus working capital and general corporate purposes
Feb 13, 2025
Private placement of securities
Closed: US$1.5M raised
Buyers: Entity affiliated with Edesa's Chief Executive Officer and Founder ($1.5 million in gross proceeds under a securities purchase agreement)
Insiders: An entity affiliated with the Chief Executive Officer and Founder provided the $1.5 million under a securities purchase agreement
Dec 13, 2024
At-the-market programme of common shares
Tranche closed: US$600,000 raised
Dec 13, 2024

Open Financings · Read by 6ix AI from the company's releases

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue0328.8K0211.8K228.3K1.27M
Cost of revenue017.6K0133.3K250.0K818.6K
Gross profit0311.2K078.5K-21.8K453.1K
Research and development3.67M2.88M4.79M13.3M17.9M3.33M1.08M2.09M1.97M1.73M
Operating income-7.91M-7.01M-9.22M-18.4M-23.7M-6.40M-1.62M-5.08M-5.22M-4.91M
Depreciation and amortization119.3K186.0K183.5K118.2K118.8K57.6K1.66K188.0K179.3K149.6K
EBITDA-7.79M-6.83M-9.04M-18.3M-23.6M-6.34M-1.62M-4.89M-5.05M-4.76M
Income before tax-7.18M-6.17M-8.37M-17.5M-13.3M-6.36M-5.04M-5.03M-5.02M
Income tax80080080080080080008008007.20K
Net income-7.19M-6.17M-8.37M-17.5M-13.3M-6.36M-1.54M-5.04M-5.03M-5.03M
Earnings per share, basic-1.27-1.93-2.93-7.37-1.10-0.74-0.47-1.76-3.44-0.57
Earnings per share, diluted-1.10-0.74-0.47-1.76-3.44-0.57

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents10.8M1.00M5.40M7.09M7.84M7.21M3.37M3.73M4.57M7.42M
Short-term investments1.60M6.08M1.99M3.99M
Receivables3.30M87.4K7.34K41.2K1.29K85.8K
Inventory0224.3K68.1K249.4K
Current assets11.5M1.68M6.44M9.09M12.1M8.10M3.39M10.7M6.76M12.1M
Property, plant and equipment08.70K12.7K15.0K14.8K7.39K1.06M879.5K756.1K
Total assets13.5M3.81M8.89M11.6M14.6M10.8M3.40M11.8M7.72M12.9M
Current liabilities1.08M1.83M1.82M2.14M1.46M1.53M183.8K493.4K320.9K623.6K
Total liabilities1.83M1.84M2.18M1.53M1.65M
Shareholders' equity12.5M1.98M7.05M9.39M13.1M6.63M3.21M3.55M7.40M12.3M
Shares outstanding7.14M3.25M3.08M2.38M13.3M9.62M3.24M5.33M1.50M10.1M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-7.32M-4.89M-6.64M-12.3M-13.7M-4.99M-1.29M-4.62M-4.70M-4.51M
Capital spending0-5.66K-6.15K-4.86K-6.87K-382.8K-302.7K-402.3K
Free cash flow-6.64M-12.3M-13.7M-4.99M-1.30M-5.00M-5.00M-4.91M
Cash from investing0-5.66K-6.15K19.1K-6.87K-4.47M1.69M557.4K
Cash from financing17.0M592.0K4.83M11.6M14.2M7.09M8.77M07.31M
Change in cash9.75M-4.32M-1.73M-748.3K625.6K2.18M-1.63M-345.4K-2.85M3.46M

Open Financials

Filings

FilingDateTypeFiled with
8-K · Current reportNov 17, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 16, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeNov 12, 2026Big-stake noticeSEC
8-K · Current reportNov 9, 2026Material contractSEC
4 · Change in ownershipNov 5, 2026Insider tradeSEC
SCHEDULE 13G/A · Big-stake notice, amendedNov 4, 2026Big-stake noticeSEC
Show 200 filings
FilingDateTypeFiled with
4 · Change in ownershipOct 29, 2026Insider tradeSEC
8-K · Current reportOct 23, 2026Management or board changeSEC
8-K · Current reportOct 15, 2026Current reportSEC
4 · Change in ownershipOct 6, 2026Insider tradeSEC
4 · Change in ownershipSep 1, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeAug 26, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 25, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedAug 25, 2026Big-stake noticeSEC
8-K · Current reportAug 20, 2026Material contractSEC
424B5 · ProspectusAug 20, 2026Offer documentSEC
424B5 · ProspectusAug 19, 2026Offer documentSEC
10-Q · Quarterly reportAug 13, 2026Quarterly reportSEC
8-K · Current reportAug 13, 2026ResultsSEC
4 · Change in ownershipAug 4, 2026Insider tradeSEC
EFFECT · Notice that a registration is effectiveJul 14, 2026Other filingsSEC
424B3 · ProspectusJul 13, 2026Offer documentSEC
4 · Change in ownershipJul 2, 2026Insider tradeSEC
S-3 · Registration statementJul 2, 2026Offer documentSEC
DJun 26, 2026Other filingsSEC
SCHEDULE 13G · Big-stake noticeJun 18, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedJun 16, 2026Big-stake noticeSEC
4 · Change in ownershipJun 16, 2026Insider tradeSEC
8-K · Current reportJun 11, 2026Material contractSEC
8-K · Current reportJun 5, 2026Current reportSEC
4 · Change in ownershipJun 1, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
4 · Change in ownershipMay 29, 2026Insider tradeSEC
S-8 · Registration statement for employee plansMay 29, 2026Offer documentSEC
8-K · Current reportMay 29, 2026Management or board changeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedMay 15, 2026Big-stake noticeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
8-K · Current reportMay 15, 2026Management or board changeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2026Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2026Quarterly reportSEC
8-K · Current reportMay 14, 2026ResultsSEC
4 · Change in ownershipMay 1, 2026Insider tradeSEC
4 · Change in ownershipApr 10, 2026Insider tradeSEC
ARS · Annual report to shareholdersApr 3, 2026Annual reportSEC
DEFA14A · Additional proxy materialApr 3, 2026Meeting noticeSEC
DEF 14A · Proxy statementApr 3, 2026Meeting noticeSEC
SCHEDULE 13G · Big-stake noticeMar 16, 2026Big-stake noticeSEC
4 · Change in ownershipMar 11, 2026Insider tradeSEC
4 · Change in ownershipMar 10, 2026Insider tradeSEC
4 · Change in ownershipMar 6, 2026Insider tradeSEC
4 · Change in ownershipMar 5, 2026Insider tradeSEC
4 · Change in ownershipMar 4, 2026Insider tradeSEC
4 · Change in ownershipMar 3, 2026Insider tradeSEC
SCHEDULE 13G · Big-stake noticeMar 3, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 2, 2026Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedMar 2, 2026Big-stake noticeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
4 · Change in ownershipMar 2, 2026Insider tradeSEC
8-K · Current reportFeb 24, 2026Current reportSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 13, 2026Big-stake noticeSEC
10-Q · Quarterly reportFeb 13, 2026Quarterly reportSEC
8-K · Current reportFeb 13, 2026ResultsSEC
4 · Change in ownershipFeb 2, 2026Insider tradeSEC
4 · Change in ownershipJan 5, 2026Insider tradeSEC
8-K · Current reportDec 12, 2025Current reportSEC
424B5 · ProspectusDec 12, 2025Offer documentSEC
10-K · Annual reportDec 12, 2025Annual reportSEC
8-K · Current reportDec 12, 2025ResultsSEC
4 · Change in ownershipDec 2, 2025Insider tradeSEC
4 · Change in ownershipNov 6, 2025Insider tradeSEC
8-K · Current reportOct 28, 2025Current reportSEC
4 · Change in ownershipOct 3, 2025Insider tradeSEC
8-K · Current reportSep 30, 2025Material contractSEC
4 · Change in ownershipSep 12, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveSep 10, 2025Other filingsSEC
8-K · Current reportSep 9, 2025Current reportSEC
424B5 · ProspectusSep 9, 2025Offer documentSEC
CORRESP · Letter to the SECSep 5, 2025Other filingsSEC
10-Q · Quarterly reportAug 8, 2025Quarterly reportSEC
8-K · Current reportAug 8, 2025ResultsSEC
4 · Change in ownershipAug 4, 2025Insider tradeSEC
UPLOAD · Letter from the SECJul 30, 2025Other filingsSEC
S-3 · Registration statementJul 25, 2025Offer documentSEC
4 · Change in ownershipJul 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
4 · Change in ownershipJun 2, 2025Insider tradeSEC
S-8 · Registration statement for employee plansMay 28, 2025Offer documentSEC
8-K · Current reportMay 28, 2025Management or board changeSEC
SCHEDULE 13G · Big-stake noticeMay 15, 2025Big-stake noticeSEC
10-Q · Quarterly reportMay 14, 2025Quarterly reportSEC
8-K · Current reportMay 14, 2025ResultsSEC
4 · Change in ownershipMay 6, 2025Insider tradeSEC
3 · Initial statement of ownershipMay 2, 2025Insider tradeSEC
ARS · Annual report to shareholdersApr 4, 2025Annual reportSEC
DEFA14A · Additional proxy materialApr 4, 2025Meeting noticeSEC
DEF 14A · Proxy statementApr 4, 2025Meeting noticeSEC
8-K · Current reportApr 4, 2025Management or board changeSEC
4 · Change in ownershipApr 3, 2025Insider tradeSEC
EFFECT · Notice that a registration is effectiveMar 12, 2025Other filingsSEC
424B3 · ProspectusMar 11, 2025Offer documentSEC
CORRESP · Letter to the SECMar 7, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 7, 2025Other filingsSEC
UPLOAD · Letter from the SECMar 4, 2025Other filingsSEC
S-3 · Registration statementMar 4, 2025Offer documentSEC
4 · Change in ownershipMar 3, 2025Insider tradeSEC
CORRESP · Letter to the SECFeb 26, 2025Other filingsSEC
SCHEDULE 13G · Big-stake noticeFeb 25, 2025Big-stake noticeSEC
UPLOAD · Letter from the SECFeb 20, 2025Other filingsSEC
3 · Initial statement of ownershipFeb 18, 2025Insider tradeSEC
SCHEDULE 13D · Big-stake noticeFeb 18, 2025Big-stake noticeSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 18, 2025Big-stake noticeSEC
SCHEDULE 13D/A · Big-stake notice, amendedFeb 14, 2025Big-stake noticeSEC
DFeb 14, 2025Other filingsSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
4 · Change in ownershipFeb 14, 2025Insider tradeSEC
10-Q · Quarterly reportFeb 14, 2025Quarterly reportSEC
8-K · Current reportFeb 14, 2025ResultsSEC
8-K · Current reportFeb 13, 2025Material contractSEC
SCHEDULE 13G/A · Big-stake notice, amendedFeb 12, 2025Big-stake noticeSEC
4 · Change in ownershipFeb 4, 2025Insider tradeSEC
4 · Change in ownershipJan 6, 2025Insider tradeSEC
10-K/A · Annual report, amendedDec 20, 2024Annual reportSEC
10-K · Annual reportDec 13, 2024Annual reportSEC
8-K · Current reportDec 13, 2024ResultsSEC
4 · Change in ownershipDec 3, 2024Insider tradeSEC
4 · Change in ownershipNov 12, 2024Insider tradeSEC
SC 13D/A · Big-stake notice, amendedNov 1, 2024Big-stake noticeSEC
4 · Change in ownershipNov 1, 2024Insider tradeSEC
8-K · Current reportOct 31, 2024Material contractSEC
424B5 · ProspectusOct 4, 2024Offer documentSEC
8-K · Current reportOct 4, 2024Material contractSEC
4 · Change in ownershipOct 2, 2024Insider tradeSEC
4 · Change in ownershipSep 3, 2024Insider tradeSEC
10-Q · Quarterly reportAug 9, 2024Quarterly reportSEC
8-K · Current reportAug 9, 2024ResultsSEC
4 · Change in ownershipAug 2, 2024Insider tradeSEC
4 · Change in ownershipJul 3, 2024Insider tradeSEC
8-K · Current reportJun 24, 2024Current reportSEC
4 · Change in ownershipJun 4, 2024Insider tradeSEC
SC 13G · Big-stake noticeJun 3, 2024Big-stake noticeSEC
S-8 · Registration statement for employee plansMay 31, 2024Offer documentSEC
8-K · Current reportMay 30, 2024Management or board changeSEC
10-Q · Quarterly reportMay 10, 2024Quarterly reportSEC
8-K · Current reportMay 10, 2024ResultsSEC
4 · Change in ownershipMay 1, 2024Insider tradeSEC
ARS · Annual report to shareholdersApr 5, 2024Annual reportSEC
DEFA14A · Additional proxy materialApr 5, 2024Meeting noticeSEC
DEF 14A · Proxy statementApr 5, 2024Meeting noticeSEC
4 · Change in ownershipApr 2, 2024Insider tradeSEC
4 · Change in ownershipMar 25, 2024Insider tradeSEC
4 · Change in ownershipMar 1, 2024Insider tradeSEC
10-Q · Quarterly reportFeb 9, 2024Quarterly reportSEC
8-K · Current reportFeb 9, 2024ResultsSEC
4 · Change in ownershipFeb 2, 2024Insider tradeSEC
SC 13G/A · Big-stake notice, amendedJan 29, 2024Big-stake noticeSEC
SC 13D/A · Big-stake notice, amendedJan 16, 2024Big-stake noticeSEC
4 · Change in ownershipJan 12, 2024Insider tradeSEC
10-K · Annual reportDec 15, 2023Annual reportSEC
8-K · Current reportDec 15, 2023ResultsSEC
8-K · Current reportOct 26, 2023Current reportSEC
8-K · Current reportOct 23, 2023Material contractSEC
8-K · Current reportOct 12, 2023Material contractSEC
8-K · Current reportOct 11, 2023Current reportSEC
SC 13D/A · Big-stake notice, amendedAug 21, 2023Big-stake noticeSEC
10-Q · Quarterly reportAug 9, 2023Quarterly reportSEC
8-K · Current reportAug 9, 2023ResultsSEC
4 · Change in ownershipAug 4, 2023Insider tradeSEC
4 · Change in ownershipAug 4, 2023Insider tradeSEC
4 · Change in ownershipAug 4, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4/A · Change in ownership, amendedJul 24, 2023Insider tradeSEC
4 · Change in ownershipJul 21, 2023Insider tradeSEC

This page holds 200 of 759 filings. Open Filings

Open Filings · All of its filings on SEC EDGAR

Cap table

Built by 6ix from Edesa Biotech, Inc.’s releases · as of Aug 20, 2026

Common shares
13,511,531
Fully diluted
13,511,531

Fully diluted

LineShares
Common shares13,511,531

Share count over time

CountShares
Nov 22, 202613,511,531

Open Cap table

Shareholders

Institutions

HolderSharesOf the companyValueAs of
Velan Capital Investment Management LP1.28M13.3%US$5.4MSep 30, 2026
Millennium1.18M12.2%US$4.96MSep 30, 2026
Boxer Capital Management, LLC937K9.7%US$3.95MSep 30, 2026
Stempoint Capital LP825K8.6%US$3.47MSep 30, 2026
Stonepine Capital Management, LLC710K7.4%US$2.99MSep 30, 2026
Rubric Capital Management LP622K6.5%US$2.62MSep 30, 2026
Perceptive Advisors LLC563K5.8%US$2.37MSep 30, 2026
Adage Capital Partners Gp, L.L.C.550K5.7%US$2.32MSep 30, 2026
Heights Capital Management, Inc204K2.1%US$858KSep 30, 2026
Vanguard121K1.3%US$508KSep 30, 2026
All 31 holders
HolderSharesOf the companyValueAs of
Geode Capital75,7890.79%US$319KSep 30, 2026
Citadel51,5510.53%US$217KSep 30, 2026
Jane Street49,9920.52%US$210KSep 30, 2026
State Street40,7790.42%US$172KSep 30, 2026
BlackRock27,4950.29%US$116KSep 30, 2026
Northern Trust14,9940.16%US$63,125Sep 30, 2026
Scotiabank14,3930.15%US$60,594Sep 30, 2026
XTX Topco Ltd11,3020.12%US$47,581Sep 30, 2026
Pinnacle Financial Group, Inc.6,0000.06%US$25,260Sep 30, 2026
SBI Securities Co., Ltd.3,5070.04%US$14,764Sep 30, 2026
Federation des caisses Desjardins du Quebec2,5950.03%US$10,925Sep 30, 2026
RBC1,6590.02%US$7,000Sep 30, 2026
McGuire Capital Advisors Inc1,5000.02%US$6,315Sep 30, 2026
Morgan Stanley1,4000.01%US$5,894Sep 30, 2026
BNP Paribas1,3320.01%US$5,608Sep 30, 2026
JPMorgan404<0.01%US$1,438Sep 30, 2026
TD142<0.01%US$567Sep 30, 2026
UBS27<0.01%US$114Sep 30, 2026
Barclays4<0.01%US$17Sep 30, 2026
Banque Cantonale Vaudoise3<0.01%Sep 30, 2026
Danske Bank A/S1<0.01%US$4Sep 30, 2026

Funds

HolderSharesOf the companyValueAs of
Vanguard Extended Market Index Fund70,4360.73%US$573KJun 30, 2026
Fidelity Extended Market Index Fund34,9810.36%US$253KMay 31, 2026
Fidelity Total Market Index Fund13,5360.14%US$97,730May 31, 2026
Fidelity Series Total Market Index Fund9,6030.10%US$69,334May 31, 2026
Fidelity Nasdaq Composite Index Fund3,8890.04%US$28,079May 31, 2026
Blackstone Alternative Multi-Strategy Fund30<0.01%US$244Jun 30, 2026

Big stakes

StakeStakeSharesDateFiling
Pardeep Nijhawan16.31%2.61MAug 21, 2026Schedule 13D
Velan Capital Investment Management LP9.99%1.36MAug 21, 2026Schedule 13D
Stempoint Capital LP9.90%1.41MSep 30, 2026Schedule 13G
Sirenia Capital Management LP9.90%3.34MSep 30, 2026Schedule 13G
Integrated Core Strategies (US) LLC8.70%1.17MSep 30, 2026Schedule 13G
Adage Capital Management, L.P.7.83%1.1MSep 30, 2026Schedule 13G
Boxer Capital Management, LLC6.90%937KSep 30, 2026Schedule 13G
Stonepine Capital Management, LLC6.90%954KAug 20, 2026Schedule 13G

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Jennifer M Chao
Other companies: Endo International PLC (Director · Feb 17, 2021 – Jun 11, 2021 · Past); BioSpecifics Technologies Corp (Director · Apr 22, 2015 – Dec 2, 2020 · Past)
Director · Mar 28, 2022 – Mar 28, 2022 · Past
Charles V Olson
Other companies: Anthera Pharmaceuticals Inc (Chief Technology Officer · Jan 5, 2016 – May 20, 2017 · Past)
Director · Since at least Dec 8, 2016
Mark A McPartland
Other companies: Vistagen Therapeutics, Inc. (VP CORPORATE DEVELOPMENT · Sep 19, 2017 – Dec 30, 2020 · Past)
(See Remarks) · Sep 1, 2014 – Dec 22, 2015 · Past
Peter van der Velden
Other companies: LAVA Medtech Acquisition Corp (Director · Oct 26, 2021 – Oct 26, 2021 · Past)
Director · Jun 7, 2019 – Apr 22, 2021 · Past
Tessie M Che
Other companies: Optimer Pharmaceuticals Inc (COO and SVP · Feb 8, 2007 – Jan 1, 2012 · Past)
Director · Sep 1, 2014 – Mar 12, 2019 · Past
Blair GordonVice President, Research and Development · Since at least Nov 4, 2026
Carlo SistilliDirector · Since at least Jun 7, 2019
Da David LiuDirector · Since at least Feb 12, 2025
David Louis HillDirector · Dec 20, 2016 – Mar 12, 2019 · Past
Deborah F AghibDirector · Jan 23, 2018 – Mar 12, 2019 · Past
All 25 people
PersonSeat
Frank R OakesDirector · Mar 12, 2018 – Jul 20, 2023 · Past
Gary KoppenjanVice President, Corporate Affairs · Since at least Aug 20, 2026
Gregory T BaxterEVP, Corporate Development · Mar 28, 2017 – Mar 12, 2018 · Past
Joan ChypyhaDirector · Since at least May 23, 2023
Kathi NiffeneggerChief Financial Officer · Sep 1, 2014 – Nov 2, 2022 · Past
Lorin K JohnsonDirector · Oct 13, 2020 – Feb 28, 2022 · Past
Mayank D SampatDirector · Sep 1, 2014 – Mar 12, 2019 · Past
Michael BrooksPresident · Since at least Jun 7, 2019
Pardeep NijhawanChief Executive Officer, Director · Since at least Jun 7, 2019
Par NijhawanChief Executive Officer · Since at least Oct 15, 2026
Patrick MarshallDirector · Since at least May 23, 2023
Paul ChunDirector · Dec 8, 2016 – Mar 12, 2019 · Past
Peter J. WeilerChief Financial Officer · Since at least May 1, 2025
Sean Arthur MacDonaldDirector · Since at least Jun 7, 2019
Stephen LemieuxChief Financial Officer · Jul 15, 2023 – Aug 4, 2023 · Past

Open People

Log in to ask 6ix AI your own questions about Edesa Biotech, Inc.